Mark Laubach is professor of neuroscience at American University. His research group focuses on understanding the prefrontal cortex and its role in learning and decision making. Laubach and his graduate students, working with Alexxai Kravitz, maintain the National Science Foundation-supported OpenBehavior project.
Mark Laubach
Professor of neuroscience
American University
From this contributor
Unleashing the power of DIY innovation in behavioral neuroscience
Widespread adoption of open-source tools calls for more support and training.
Unleashing the power of DIY innovation in behavioral neuroscience
By
Alexxai Kravitz, Mark Laubach
2 April 2024 | 0 min watch
Explore more from The Transmitter
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
Double-duty neurons in primary olfactory cortex pick up on more than just scent
The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.
By
Angie Voyles Askham
9 October 2024 | 7 min read
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan
The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.
By
Olivia Gieger
9 October 2024 | 7 min read
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read